InsiderFlow

James E Flynn

NUVL

James E Flynn serves as director, 10 percent owner, other: * Director by Deputization at Nuvalent, Inc. (NUVL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$56.26M

Total Sells

3 trades

$88.35M

Net Position

Net Seller

$32.09M

Companies Traded

5

LRMR, NUVL, SPRY, BCAX

Active Period

Mar 2024 – Mar 2026

6 total trades

Most Recent

Buy LRMR

Mar 2, 2026 · $25.00M

James E Flynn's Insider Trading at Nuvalent, Inc. (NUVL)

Buys

0 · $0.00

Sells

1 · $70.88M

Total Shares Bought

0

Total Shares Sold

742,574

NUVL Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Nov 24, 2025Sell742,574$95.45$70.88M0

James E Flynn's Insider Trading at Larimar Therapeutics, Inc. (LRMR)

Buys

2 · $55.00M

Sells

0 · $0.00

Total Shares Bought

14,375,000

Total Shares Sold

0

LRMR Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Mar 2, 2026Buy5,000,000$5.00$25.00M10,623,000
Jul 31, 2025Buy9,375,000$3.20$30.00M0

James E Flynn's Insider Trading at ARS Pharmaceuticals, Inc. (SPRY)

Buys

0 · $0.00

Sells

1 · $13.66M

Total Shares Bought

0

Total Shares Sold

740,149

SPRY Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Jun 27, 2025Sell740,149$18.46$13.66M0

James E Flynn's Insider Trading at AdaptHealth Corp. (AHCO)

Buys

0 · $0.00

Sells

1 · $3.82M

Total Shares Bought

0

Total Shares Sold

350,000

AHCO Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Mar 8, 2024Sell350,000$10.90$3.82M0

James E Flynn's Insider Trading at Bicara Therapeutics Inc. Common Stock (BCAX)

Buys

1 · $1.26M

Sells

0 · $0.00

Total Shares Bought

70,000

Total Shares Sold

0

BCAX Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Sep 17, 2024Buy70,000$18.00$1.26M0